Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank83
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-27.78M
↑ 19% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-34.41M
Historical baseline
PeriodValueYoY Change
TTM$-27.78M+22.3%
2024$-35.76M+31.8%
2023$-52.47M-9.0%
2022$-48.13M-47.0%
2021$-32.75M-102.7%
2020$-16.16M+42.0%
2019$-27.85M-